MYM.CN - MYM Nutraceuticals Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 59.24M
Enterprise Value 37.17M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.18
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.50

Trading Information

Stock Price History

Beta (5Y Monthly) 0.92
52-Week Change 3-88.46%
S&P500 52-Week Change 3-12.65%
52 Week High 30.5600
52 Week Low 30.0500
50-Day Moving Average 30.0711
200-Day Moving Average 30.1224

Share Statistics

Avg Vol (3 month) 3456.39k
Avg Vol (10 day) 3155.17k
Shares Outstanding 5154.03M
Float 145.51M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Feb. 13, 2020) 4129.33k
Short Ratio (Feb. 13, 2020) 40.28
Short % of Float (Feb. 13, 2020) 4N/A
Short % of Shares Outstanding (Feb. 13, 2020) 40.08%
Shares Short (prior month Jan. 14, 2020) 442.77k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2019
Most Recent Quarter (mrq)Nov. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-65.52%
Return on Equity (ttm)-186.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.33M
Net Income Avi to Common (ttm)-23.22M
Diluted EPS (ttm)-0.1780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.65M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)733.61k
Total Debt/Equity (mrq)11.08
Current Ratio (mrq)2.71
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-6.63M
Levered Free Cash Flow (ttm)-3.33M